TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology.
TheraCell’s DBF is incorporated into AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat demineralized cortical fiber allografts, commercialized by AlloSource and launched in 2016.
Sources: TheraCell, Inc.; ORTHOWORLD Inc.
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology.
TheraCell’s DBF is...
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology.
TheraCell’s DBF is incorporated into AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat demineralized cortical fiber allografts, commercialized by AlloSource and launched in 2016.
Sources: TheraCell, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
